GSK Investigational Site

Montclair, California 91763

1 studies enrolling now · 3 studies all time

What they study most

Non-alcoholic Fatty Liver Disease, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH — Recruiting now
• Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH — Completed
• Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease — Completed